Implications and Consequences of Antimicrobial Therapy for the Development and Transfer Of Resistance

  • D. Van Der Waaij
Part of the New Perspectives in Clinical Microbiology book series (NPCM, volume 5)

Abstract

Since antimicrobial drugs first became available for the treatment of infections, resistance has developed (1–12). The increase in the number of antibiotics and in the diversity of their spectrum of activity in the last few decades has not solved the problem: the use of new antibiotics has invariably led to the development of resistance after some time. Bacteria of many different species have proven to have an almost endless capacity to develop sublines of strains that are resistant, often to more than one antibiotic.

Keywords

Bacillus Tetracycline Gentamicin Candida Erythromycin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Julianelle, L.A., Siegel, M. 1945. The epidemiology of acute respiratory infections conditioned by sulfonamides. II. Gross alterations in the naso—pharyngeal flora associated with treatment. Ann. Int. Med. 22: 10.Google Scholar
  2. 2.
    Weinstein, L. 1947. The spontaneous occurrence of new bacterial infections during the course of treatment with streptomycin or penicillin. Am. J. Med. 214: 56.CrossRefGoogle Scholar
  3. 3.
    Smith, D.T. 1952. The disturbance of the normal bacterial ecology by the administration of antibiotics with the development of new clinical syndromes. Ann. Int. Med. 27: 1135.Google Scholar
  4. 4.
    Louria, D.B., Kaminski, Th. 1962. The effects of four antimicrobial drug regimens on sputum superinfection in hospitalized patients. Am. Rev. Resp. Dis. 85: 649.PubMedGoogle Scholar
  5. 5.
    Finegold, S.M., Harada, N.E., Miller, L.G. 1965. Lyncomycin: Activity against anaerobes and effect on normal human fecal flora. Antimicrob. Agents Chemother. 5: 659.Google Scholar
  6. 6.
    Sompolinski, D., Yaron, V., Alkan, W.J. 1967. Microbiological changes in the human fecal flora following the administration of tetracyclines and chloramphenicol. Am. J. Proctol. 18: 471.Google Scholar
  7. 7.
    Rose, H.D., Schreier, J. 1968. The effect of hospitalization and antibiotic therapy on the Gram-negative fecal flora. Am. J. Med. Sci. 255: 228.PubMedCrossRefGoogle Scholar
  8. 8.
    Shaw, E.J., Datta, N., Jones, G., Marr, F.M., Froud, W.K.B. 1973. Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of bowel coliforms. J. Hyg. 71: 529.CrossRefGoogle Scholar
  9. 9.
    Hirsh, D.C., Burton, G.C., Blenden, D.C. 1974. The effect of tetracycline upon establishment of Escherichia coli of bovine origin in the enteric tract of man. J. Appl. Bact. 37: 327.CrossRefGoogle Scholar
  10. 10.
    Gaman, W., Cates, C., Snelling, C.F.T., Lank, B., Ronald, A.R. 1976. Emergence of gentamicin- and carbicillinresistant Pseudomonas aeruginosa in a hospital environment. Antimicrob. Agents Chemother. 9: 474.PubMedGoogle Scholar
  11. 11.
    Roberts, N., Douglas, R.G. 1978. Gentamicin use and Pseudomonas and Serratia resistance: Effect of a surgical prophylaxis regimen. Antimicrob. Agents Chemother. 13: 214.Google Scholar
  12. 12.
    Chow, A.W., Taylor, Ph.R., Yoshikawa, T.T., Guze, L.B. 1978. A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: Role of intestinal colonization as a major reservoir. J. Inf. Dis. 139: 621.Google Scholar
  13. 13.
    Waaij van der, D., Vries de, J.M., Lekkerkerk, J.E.C. 1971. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. 69: 405.CrossRefGoogle Scholar
  14. 14.
    Waaij van der, D. 1979. The colonization resistance of the digestive tract in man and animals. Zbl. Bakt. Suppl. 7: 155.Google Scholar
  15. 15.
    Laufs, R., Fock, R., Von Hulst, F.B., Ritter, R. 1979. Transfer of R-factors during antibiotic treatment in the hospital. In: New Criteria for antimicrobial therapy: Maintenance of digestive tract colonization resistance. Eds D. van der Waaij, J. Verhoef. Excerpta Medica. Amsterdam, Oxford. 74.Google Scholar
  16. 16.
    Evans, D.G., Silver, R.P., Evans, D.J., Chase, D.G., Gorbach, S.L. 1975. Plasmid-controlled colonization factor associated with virulence in Escherichia coli enterotoxin for humans. Infect. Immun. 12: 656.Google Scholar
  17. 17.
    Nandadasa, H.G., Sargent, G.F., Brown, M.G.M., McNeish, A.S., Williams, P.H. 1981. The role of plasmids in adherence of adhesive Escherichia coli to mammalian cells. J. Inf. Dis. 143: 286.Google Scholar
  18. 18.
    Echeverria, P., Murphy, J.R. 1980. Enteroxigenic Escherichia coli carrying plasmids coding for antibiotic resistance and enterotoxin production. J. Inf. Dis. 142: 273.Google Scholar
  19. 19.
    Waaij van der, D. 1979. Th colonization resistance of the digestive tract in experimental animals and its consequence for infection prevention, acquisition of new bacteria and the prevention of spread of bacteria between cage mates. In: New criteria for antimicrobial therapy: Maintenance of digestive tract colonization resistance. Eds D. van der Waaij, J. Verhoef. Excerpta Medica. Amsterdam, Oxford. 43.Google Scholar
  20. 20.
    Louria, D.B., Brayton, R.G C 1963. The efficacy of penicillin regimens: With observations on the frequency of superinfections. JAMA 186: 987.Google Scholar
  21. 21.
    Gorbach, S.L., Spanknebel, G., Weinstein, L., Plant, A.G., Nahas, L., Levitan, R. 1969. Studies of intestinal microflora. VIII. Effect of Lincomycin on the microbial population of the human intestine. J. Inf. Dis. 120: 298.Google Scholar
  22. 22.
    Hinton, N.A. 1970. The effect of oral tetracyclin-HCl and doxycycline on the intestinal flora. Curr. Ther. Res. 12: 341.Google Scholar
  23. 23.
    Hartley, Ch.L, Clements, H.M., Linton, K.B. 1977. Effects of cephalexin erythromycin and clindamycin on the anerobic Gram-negative faecal flora in man. J. Med. Microbiol. 11: 125.Google Scholar
  24. 24.
    Thijm, H.A., Waaij van der, D. 1979. The effect of three frequently applied antibiotics on the colonization resistance of the digestive tract of mice. J. Hyg. 82: 397.CrossRefGoogle Scholar
  25. 25.
    Emmelot, C.H., Waaij van der, D. 1980. The dose at which neomycin and polymixin B can be applied for selective decontamination of the digestive tract in mice. J. Hyg. 84: 331.CrossRefGoogle Scholar
  26. 26.
    Waaij van der, D., Aberson, J., Thijm, A.H., Welling, G.W. 1982. The screening of four aminoglycosides in the selective decontamination of the digestive tract in mice. Infection 10: 35.PubMedCrossRefGoogle Scholar
  27. 27.
    Wiegersma, N., Jansen, G., Waaij van der, D. 1982. Effect of twelve antimicrobial drugs on the colonization resistance of the digestive tract of mice an on endogenous potentially pathogenic bacteria. J. Hyg. In press.Google Scholar
  28. 28.
    Waaij van der, D. 1979. Colonization resistance of the digestive tract as a major lead in the selection of antibiotics for therapy. In: New criteria for antimicrobial therapy: Maintenance of digestive tract colonization resistance. Eds D. van der Waaij, J. Verhoef. Excerpta Medica. Amsterdam, Oxford. 271.Google Scholar
  29. 29.
    Waaij van der, D., Hofstra, W., Wiegersma, N. 1982. The effect of two cephalosporins and two broad-spectrum penicillins on the colonization resistance of the digestive tract. J. Inf. Dis. In press.Google Scholar
  30. 30.
    Murray, B.E., Rensimer, E.D., DuPont, H.L. 1982. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl. J. Med. 306: 130.Google Scholar
  31. 31.
    Sleijfer, D.Th., Mulder, N.H., Vries de-Hospers, H.G., Fidler, V., Nieweg, H.O., Waaij van der, D., Saene van,H.K.F. 1980. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur. J. Cancer 16: 859.Google Scholar
  32. 32.
    Saene van, H.K.F., Driessen, L.H.M.N. 1979. Importance of the treatment of Staphylococcus aureus carriership in the prevention and therapy of Staphylococcus aureus infections. In: New criteria for antimicrobial therapy: Maintenance of digestive tract colonization resistance. Eds D. van der Waaij, J. Verhoef. Excerpta Medica. Amsterdam, Oxford. 197.Google Scholar
  33. 33.
    Vries de-Hospers, H.G., Sleijfer, D.Th., Mulder, N.H., Waaij van der, D., Nieweg, H.O., Saene van, H.K.F. 1981. Bacterial aspects of selective decontamination of the digestive tract as a method of infection prevention in granulopenic patients. Antimicrob. Agents Chemother. 19: 813.Google Scholar
  34. 34.
    Guiot, H.F.L., Meer van der, J.W.M., Furth van, R. 1981. Selective antimicrobial modulation of human microbial flora. Infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J. Inf. Dis. 143: 644.CrossRefGoogle Scholar
  35. 35.
    Jehn, U., Ruckdeschell, G., Saner, H., Clemm, Ch., Wilmans, W. 1981. Vergleichende Studie zum Wert der Selektiven Darmdekontamination (SDD) bei der Behandlung akuter leukämien. Klin. Wochenschr. 59: 1093.PubMedCrossRefGoogle Scholar
  36. 36.
    Kurrle, E. 1981. Infektprophylaxe bei der Induktion Therapie akuter leukämien. Klin. Wochenschr. 59: 1085.CrossRefGoogle Scholar
  37. 37.
    Dekker, A.W., Rozenberg-Arska, M., Sixma, J.J., Verhoef, J. 1982. Prevention of infection by co-trimoxazole in patients with acute non-lymphocytic leukemia. Ann. Int. Med. 95: 555.Google Scholar
  38. 38.
    Wilson, J.M., Guiney, D.G. 1982. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukaemia. N. Engl. J. Med. 306: 16.PubMedCrossRefGoogle Scholar
  39. 39.
    Watson, J.G., Powels, R.L., Lawson, D.N., Morgenstern, G.R., Jameson, B., McElwain, T.J., Judson, I., Lumley, H., Kay, H.E.M. 1982. Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet i: 6.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1982

Authors and Affiliations

  • D. Van Der Waaij

There are no affiliations available

Personalised recommendations